Table 3 |
||||||
|
Expression of CK7, CK20, and CDX2 in cancer tissues by histopathological characteristics |
||||||
|
CK7+ |
CK20+ |
CDX2+ |
||||
|
|
|
|
||||
|
n |
% |
n |
% |
n |
% |
|
|
|
||||||
|
Colorectal adenocarcinoma (n = 118) |
||||||
|
Low grade (n = 96) |
22 |
22.9 |
87 |
90.6 * |
94 |
97.9 |
|
High grade (n = 22) |
4 |
18.2 |
12 |
54.5 * |
20 |
90.9 |
|
Rectal (n = 85) |
18 |
21.2 |
76 |
89.4§ |
83 |
97.6 |
|
Nonrectal (n = 33) |
8 |
24.2 |
23 |
69.7§ |
31 |
93.9 |
|
Gastric adenocarcinoma (n = 59) |
||||||
|
Intestinal type (n = 30) |
21 |
70.0 |
16 |
53.3 |
23 |
76.7 # |
|
Diffuse type (n = 29) |
26 |
89.7 |
15 |
51.7 |
13 |
44.8 # |
|
Pancreatic adenocarcinoma (n = 32) |
||||||
|
Low grade (n = 30) |
30 |
100.0 |
7 |
23.3 |
5 |
16.7 |
|
High grade (n = 2) |
1 |
50.0 |
0 |
0.0 |
0 |
0.0 |
|
|
||||||
|
* p < 0.001 § p = 0.009 # p = 0.012 |
||||||
|
Bayrak et al. Diagnostic Pathology 2012 7:9 doi:10.1186/1746-1596-7-9 |
||||||
